Markers of diabetic nephropathy (Q41689300)

7 October 2017

1 reference

title

Markers of diabetic nephropathy (English)

1 reference

7 October 2017

Hong CY

1

1 reference

7 October 2017

Chia KS

series ordinal

2

1 reference

7 October 2017

publication date

1 January 1998

1 reference

Journal of Diabetes and its Complications

7 October 2017

published in

1 reference

7 October 2017

volume

12

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

43-60

1 reference

LONGEVITY OF DIABETIC PATIENTS IN RECENT YEARS

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Epidemiology of end-stage renal disease in patients with diabetes mellitus: from the dark ages to the middle ages

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Diabetes and renal mortality in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Microalbuminuria in elderly hyperglycaemic patients and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Proteinuria in newly diagnosed type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Microalbuminuria predicts mortality in non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Urinary excretion and renal clearance of specific plasma proteins in diabetes of short and long duration

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Spectrum of Proteinuria in Type I and Type II Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Urinary Transferrin Excretion in Type 1 (Insulin-dependent) Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Increased Urinary Excretion of Transferrin in Children with Type 1 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Quantitative assessment of urinary protein and enzyme excretion--a diagnostic programme for the detection of renal involvement in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Glomerular and tubular proteinuria in type 1 (insulin-dependent) diabetic patients with and without retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Increased Urinary Transferrin Excretion in Exercising Normoalbuminuric Insulin-Dependent Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Transferrinuria in Type 2 Diabetes: The Effect of Glycaemic Control

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Changes in the glomerular pore size selectivity in patients with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

The association of non-insulin-dependent diabetes mellitus and hypertension with urinary excretion of albumin and transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Glomerular clearance and tubular reabsorption of transferrin in microtransferrinuric patients with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Synthesis of fibronectin by cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

The detection, immunofluorescent localization, and thrombin induced release of human platelet-associated fibronectin antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Increased Adhesion of Erythrocytes to Endothelial Cells in Diabetes Mellitus and Its Relation to Vascular Complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Raised plasma fibronectin concentration is related to the presence of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Increased plasma fibronectin concentration in diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Relationship between urinary excretion of fibronectin degradation products and proteinuria in diabetic patients, and their suppression after continuous subcutaneous heparin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Structure and function of laminin: anatomy of a multidomain glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

The laminins: a family of basement membrane glycoproteins important in cell differentiation and tumor metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Concentrations of 7S collagen and laminin P1 in sera of patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Clinical implications of serum levels of basement membrane components in diabetic patients with and without albuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Serum concentrations of basement membrane proteins in NIDDM as a prognostic marker for nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Clinical significance of urinary laminin P1 in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Renal tubular basement membrane and collagen type IV in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Serum concentrations of intact type IV collagen in diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Serum or urinary concentration of type IV collagen in diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Increased concentrations of the basement membrane component type IV collagen in sera and urine of diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Elevated glucose decreases the content of a basement membrane associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Urinary heparan sulphate proteoglycan excretion is abnormal in insulin dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Markers of tubular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

The proteinuria of renal tubular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Proteinuria in chronic cadmium poisoning. IV. Gel filtration and ion exchange chromatography of urinary proteins from cadmium workers.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

A urinary and plasma α1-glycoprotein of low molecular weight: Isolation and some properties

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Early diagnosis of renal malfunction in diabetics. Abnormal proteinuria revealed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

The Serum Levels and Urinary Excretion of β2-Microglobulin in Apparently Healthy Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Urinary excretion of brush-border antigen and plasma proteins in early stages of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Reversible tubular proteinuria precedes microalbuminuria and correlates with the metabolic status in diabetic children

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Diurnal variation in urinary protein excretion in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Glomerular lesions in patients with non-insulin-dependent diabetes mellitus and microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

A prospective study of clinical and metabolic associates of proteinuria in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Morbidity, mortality, and albuminuria in type 2 diabetic patients: a three-year prospective study of a random cohort in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Changes in urinary retinol binding protein excretion and other indices of renal tubular damage in patients with non-insulin dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Contribution of hyperglycemia and renal damage to urinary C-peptide clearance in non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Preclinical detection of nephrotoxicity: description of the tests and appraisal of their health significance

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Stability of beta 2-microglobulin and retinol binding protein at different values of pH and temperature in normal and pathological urine

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Comparison of retinol-binding protein and β2-microglobulin determination in urine for the early detection of tubular proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Increased urinary excretion of the retinol-binding protein in insulin-dependent diabetes mellitus in the absence of microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Retinol binding protein as a small molecular weight marker of renal tubular function in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Effect of posture and acute glycaemic control on the excretion of retinol-binding protein in normoalbuminuric insulin-dependent diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

24-h ambulatory blood pressure, daytime and nighttime urinary albumin and retinol-binding protein excretion in type I diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Effect of Metabolic Control on Serum Protein Concentrations in Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

alpha 1-Microglobulin determination in urine for the early detection of renal tubular dysfunctions caused by exposure to cadmium

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Tamm-Horsfall-Protein excretion as a marker of ascending limb transport indicates early renal tubular damage in diabetes mellitus type I

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Influence of glycemic control and hypertension on urinary microprotein excretion in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Beta 2-glycoprotein-1 (apolipoprotein H) excretion and renal tubular malfunction in diabetic patients without clinical proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Use of urinary enzymes as markers of nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Urinary N-acetyl-beta-glucosaminidase activity in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

A Six-year Follow-up of the Relationship Between N-Acetyl-β-glucosaminidase and Albuminuria in Relation to Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Early changes of serum N-acetyl-beta-glucosaminidase, tissue plasminogen activator and erythrocyte superoxide dismutase in relation to retinopathy in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

[The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy]

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Enzymuria in non-insulin-dependent diabetic patients: signs of tubular cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Clinical significance of urinary enzymes in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

Urinary excretion of brush-border antigen revealed by monoclonal antibody: early indicator of toxic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2897%2900045-7

7 January 2021

10.1016/S1056-8727(97)00045-7

Identifiers

DOI

1 reference

release_gaexkgprbjewrmwf2isbu25sv4

7 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gaexkgprbjewrmwf2isbu25sv4

24 November 2022

mapped directly with Wikidata item

1 reference